Tag: Inari Medical
VenaCore device offers long-awaited interventional solution for challenging venous occlusions
This advertorial is sponsored by Inari Medical.
Despite the recent growth in mechanical thrombectomy devices for acute deep vein thrombosis (DVT), interventional options for wall...
Inari Medical updates ClotTriever XL IFU amid FDA recall notice
The Food and Drug Administration (FDA) has issued a Class I recall—the most serious type—for Inari Medical's ClotTriever XL, 30mm device due to reports...
Tackling DVT head on: Single-session, wall-to-wall thrombus removal with the ClotTriever...
This advertorial is sponsored by Inari Medical.
Several years ago, when Nicolas Mouawad, MD, division chief of vascular surgery at McLaren Health in Bay City,...
Mechanical thrombectomy demonstrates superior outcomes to anticoagulation in DVT patients, analysis...
Mechanical thrombectomy using the ClotTriever device (Inari Medical) for iliofemoral deep vein thrombosis (DVT) was found to be “associated with significantly” lower Villalta scores...
LimFlow announces agreement to be acquired by Inari Medical
LimFlow announced today that it has entered into a definitive agreement to be acquired by Inari Medical.
A press release details that, under the terms...
One-year CLOUT data demonstrate low rate of PTS following treatment with...
David Dexter (Sentara Vascular Specialists, Norfolk, USA) shared one-year data from the CLOUT registry this week at The VEINS 2023 (28–30 October, Las Vegas,...
REAL-PE demonstrates statistically significant lower major bleeding rates with Ekos system...
Data from the REAL-PE study were presented this week at TCT 2023 (23–26 October, San Francisco, USA) demonstrating that patients treated for pulmonary embolism...
Behind the procedure: Removing in-stent thrombosis with the RevCore Thrombectomy Catheter
This advertorial is sponsored by Inari Medical.
For patients with in-stent thrombosis (IST), one of the most critical unmet needs has been an effective method...
ACC 2023: Large bore mechanical thrombectomy reduces adverse outcomes in high-risk...
Large bore mechanical thrombectomy with the FlowTriever system (Inari Medical) in patients with high-risk pulmonary embolism (PE) was associated with a significantly lower occurrence...
First patient enrolled in DEFIANCE trial of the ClotTriever system in...
Inari Medical announced that the first patient has been enrolled in DEFIANCE, a prospective randomized controlled trial (RCT) comparing the clinical outcomes of patients...
Mechanical thrombectomy for DVT: Randomized data needed to boost growing evidence...
Two datasets presented during the late-breaking clinical trials session at The VEINS (Venous Endovascular Interventional Strategies) 2022 (Oct. 30–31) in Las Vegas—the latest results...
FLASH results demonstrate ‘excellent safety profile’ of the FlowTriever system in...
Results of the FLASH registry demonstrate the “excellent safety profile” of the FlowTriever system (Inari Medical) in 800 real-world patients.
This is according to Catalin...
Clinical outcomes of the ClotTriever system in DVT set to be...
Inari Medical has announced planned enrollment of the DEFIANCE randomized controlled trial (RCT), which is designed to compare the clinical outcomes of patients with...
First patient enrolled in PEERLESS study of FlowTriever system
Inari Medical has announced that the first patient has been enrolled in PEERLESS prospective, randomized controlled trial (RCT) comparing the outcomes of patients with...
Registry data show greater clot chronicity on post-procedure inspection than initially...
Nearly half of patients deemed pre-procedurally to be suffering an acute case of deep vein thrombosis (DVT) turned out to have a “much more”...
First pulmonary embolism patient enrolled in FLAME study
Inari Medical has announced the enrollment of the first high-risk pulmonary embolism (PE) patient in the FLAME (FlowTriever for acute massive pulmonary embolism) study....